skip to content

Energy

Interdisciplinary Research Centre
 
Date: 
Thursday, 19 May, 2016 - 17:30 to 19:00
Event location: 
Buckingham House, Murray Edwards College

Dr S T Lee Public Policy Lecture 2016

Professor Dame Anne Glover

Chair: Professor Sir Leszek Borysiewicz, Vice Chancellor, University of Cambridge

Venue: Buckingham House, Murray Edwards College (17:30 - 19:00 followed by drinks)

Anne Glover was the first Chief Scientific Adviser to the President of the European Commission (2012-2015). Prior to that, she was the first Chief Scientific Adviser for Scotland (2006-2011). In both positions Anne transformed the way science, engineering and technology were used and discussed within government and developed strategic initiatives to bridge the gap between science and policy. She has also been a very effective and well respected ambassador for European science. She is currently Vice Principal for External Affairs and Dean for Europe at the University of Aberdeen

In her talk, Dame Anne will examine what mechanisms could be the most effective in the European Commission for delivering evidence-based decision making.

The policies arising from the European Union are generally quite technical in nature and so evidence is a crucial part of getting the best policy outcomes. But the European Union is also a complicated social and political environment with routine complex negotiations between 28 Member States with different economies, objectives and cultures. In the EU, perhaps more than in any one Member State, scientific advice could enable better decision making and have a powerful leadership role in highlighting the value of basing policy on evidence.

Attendance at the lecture is by registration only. To register, please sign up here.

S T Lee Public Policy Lectures

The S T Lee Public Policy lectures were established in 2003 thanks to a benefaction from Seng Tee Lee, Singaporean business executive, philanthropist and Honarary Fellow of Wolfson College, Cambridge. Each lecture considers aspects of scientific, medical or technological research and developments that are likely to have significant implications for public policy over the next decade.